Report #2853506

Received Aug 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 11 yrs
State: CA
Recovered: Unknown
Vaccinated: Aug 1, 2025
Onset: Aug 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	AMAB044A	—

Symptoms (1)

Expired product administered

Symptom narrative

Menveo expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAB044A, expiry date 31-JUL-2025) for prophylaxis. On 01-AUG-2025, the patient received Menveo. On 01-AUG-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-AUG-2025 The practice manager called on 4th August 2025, to report that on 1st August 2025, a dose of Menveo with an expiration date of 31st July 2025, had been administered to a patient, which led to Expired vaccine used. The Menveo given was the 2-vial formulation.